The most important systemic factor that influences iron availability is hepcidin, a circulating peptide that maintains iron homeostasis. indicate that hypoxia-inducible factor-2 is not directly involved in hepcidin repression, they highlight the contribution of hepatic hypoxia-inducible factor-2 to the repression of hepcidin through erythropoietin-mediated increased erythropoiesis, a result of potential clinical interest. Keywords:hepatic HIF-2, hepcidin expression, erythropoiesis == Introduction == An adequate supply of oxygen in tissues is necessary for survival and normal organ function. The number of circulating red blood cells is the major determinant of tissue oxygenation. As a consequence, lack of oxygen (hypoxia) triggers induction of erythropoietin to increase the production of new red blood cells. The liver is the primary source of erythropoietin during embryogenesis, however in adults, the site of erythropoietin production switches from the fetal liver to the kidney.1 Doxycycline Hypoxia-inducible factor-1 (HIF-1) was initially identified in 1992 as a transcriptional factor able to regulate erythropoietin production.2A number of laboratories have since demonstrated that HIF-1 is implicated in most aspects of hypoxia-induced gene expression, and operates not only in kidneys but also in a wide range of organs and cell types. HIF is a heterodimeric transcription factor stabilized by low oxygen concentrations. HIF consists of two helix-loop-helix proteins: an -regulatory subunit, which is the oxygen and iron-responsive component, and the -subunit, also known as the aryl hydrocarbon receptor nuclear translocator (ARNT), which is constitutively expressed. Three regulatory HIF subunits have been cloned and named HIF-1, HIF-2 and HIF-3. In the presence of oxygen, the regulatory subunit is hydroxylated on two proline residues by the oxygen and iron-dependent prolyl-hydroxylases (PHD); the subunit is then targeted for degradation to the proteasome by interacting with the von Hippel-Lindau (VHL) E3 ubiquitin ligase tumor suppressor protein. Under hypoxia, the activity of PHD is inhibited, therefore permitting HIF- to escape degradation and translocate into the nucleus, where it binds to HIF-/ARNT. The HIF heterodimer binds to hypoxic response elements (HRE) of target gene regulatory sequences, and recruits transcriptional cofactors such as core binding protein (CBP) and p300 to induce the expression of genes involved in the control of metabolism and angiogenesis, as well as apoptosis, cellular stress and other critical processes. More than a decade after the discovery of HIF which led in turn to the discovery of VHL and various PHD, mutations in genes encoding all three of these essential components of the oxygen-sensing axis have been identified in humans with familial erythrocytosis.3 To perform their duty as oxygen carriers, erythrocytes require iron and failure to incorporate adequate iron into heme results in impaired erythrocyte maturation, leading to microcytic, hypochromic anemia. The most important systemic factor that influences iron availability is hepcidin, a circulating peptide that maintains iron homeostasis. Hepcidin is an hyposideremic hormone made predominantly by hepatocytes; it acts to down-regulate iron absorption by the duodenal enterocytes and iron Doxycycline release by the macrophages.4 Hepcidin expression is increased by iron loading, thus avoiding an excess of free toxic iron in the body, and decreased in response to hypoxia, iron deficiency and increased erythropoiesis allowing iron supply to match the erythropoietic demand.4 Recently, the bone morphogenetic protein 6 (BMP6)/hemojuvelin (HJV) signaling cascade has emerged as the principal pathway in the regulation of hepcidin gene expression.4BMP6 signals through a BMP-receptor complex that requires HJV as a co-receptor. In addition, type II transmembrane serine proteinase (TMPRSS6) encoding liver matriptase 2 has recently been identified as a repressor of hepcidin gene expression5able to antagonize hepcidin induction by BMP6 by cleaving HJV from the cell membrane.6Finally, HJV was shown to be cleaved by the furin proconvertase, which releases a soluble form of HJV that suppresses BMP signaling and hepcidin expression by acting as a decoy that competes with membrane HJV for BMP ligands.7 We previously reported that HIF control iron homeostasis by repressing hepcidin synthesis in the liver8and Doxycycline the VHLR200W mutation Doxycycline has KMT3B antibody been shown to be associated with down-regulation of hepcidin expression in patients with Chuvash polycythemia.9A marked down-regulation of hepcidin was observed in conditional knockout ofVhlhin the liver, in which both HIF-1 and HIF-2 were stabilized.8However, deletion ofHif1aalone in the liver of adult mice accounted for only a small fraction of hepcidin repression in response to an iron-deficient diet, thus possibly suggesting that.